A61P 7/10
Antioedematous agents
Official title: Antioedematous agents; Diuretics
A61P7/10 (Antioedematous agents) appears on 2,408 US grants and 3,209 published applications in this corpus.
Search patents in A61P- Granted patents
- 2,408
- Published applications
- 3,209
- Assignees
- 1,151
- Inventors
- 6,181
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 16 | 0 |
| 1977 | 10 | 0 |
| 1978 | 19 | 0 |
| 1979 | 15 | 0 |
| 1980 | 13 | 0 |
| 1981 | 19 | 0 |
| 1982 | 18 | 0 |
| 1983 | 13 | 0 |
| 1984 | 20 | 0 |
| 1985 | 23 | 0 |
| 1986 | 27 | 0 |
| 1987 | 33 | 0 |
| 1988 | 23 | 0 |
| 1989 | 23 | 0 |
| 1990 | 31 | 0 |
| 1991 | 22 | 0 |
| 1992 | 16 | 0 |
| 1993 | 15 | 0 |
| 1994 | 14 | 0 |
| 1995 | 10 | 0 |
| 1996 | 22 | 0 |
| 1997 | 12 | 0 |
| 1998 | 28 | 0 |
| 1999 | 17 | 0 |
| 2000 | 19 | 0 |
| 2001 | 12 | 6 |
| 2002 | 23 | 37 |
| 2003 | 31 | 72 |
| 2004 | 24 | 123 |
| 2005 | 31 | 125 |
| 2006 | 44 | 115 |
| 2007 | 56 | 141 |
| 2008 | 54 | 143 |
| 2009 | 67 | 205 |
| 2010 | 92 | 212 |
| 2011 | 112 | 213 |
| 2012 | 151 | 249 |
| 2013 | 170 | 222 |
| 2014 | 183 | 225 |
| 2015 | 160 | 185 |
| 2016 | 134 | 167 |
| 2017 | 128 | 132 |
| 2018 | 95 | 127 |
| 2019 | 99 | 107 |
| 2020 | 59 | 92 |
| 2021 | 65 | 81 |
| 2022 | 42 | 53 |
| 2023 | 31 | 58 |
| 2024 | 25 | 49 |
| 2025 | 28 | 45 |
| 2026 | 14 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Medical use of cystic fibrosis transmembrane conductance regulator (CFTR) modulators8 Sep 2026US 12,728,124 B2Borealis AG
- Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-IG scaffold for use in intervention and therapy of congestion in a patient in need thereof25 Aug 2026US 12,715,911 B2Adrenomed AG
- Anti-CD154 antibody having improved binding, functional and safety characteristics and use in human immunotherapy16 Jun 2026US 12,653,884 B2Immunext, Inc.
- Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith9 Jun 2026US 12,648,914 B2Eupraxia Pharmaceuticals USA LLC
- Prophylaxis and treatment of angioedema19 May 2026US 12,629,363 B2Pharvaris GmbH
- Pharmaceutical formulations for subcutaneous administration of furosemide10 Sep 2026US 2026/0263412 A1scPharmaceuticals Inc.
- Methods for in vivo editing of klkb120 Aug 2026US 2026/0240959 A1Intellia Therapeutics, Inc.
- Methods of treatment using loop diuretics13 Aug 2026US 2026/0232621 A1scPharmaceuticals Inc.
- Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack13 Aug 2026US 2026/0234289 A1Takeda Pharmaceutical Company Limited
- Pyrazolidine-3, 5-dione based compounds and a process for preparation thereof30 Jul 2026US 2026/0217657 A1Council of Scientific and Industrial Research
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Antibody compositions for selectively inhibiting VEGF356US 6,342,219 B12002
- Aminoacid derivatives as antihypertensives354US 4,374,829 AMerck & Co., Inc. · 1983